*00.020.040.060.080.10.120.140.16DMSO PHXTriglyceride (mM)B
cyt. HSP70
TubulinControl #1 #2mtHSP70 siRNA mtHSP70mtHSP70cyt. HSP70
TubulinDMSO 400PHX (nM)A
TubulinRelative band intensitycyt. HSP70mtHSP70 siRNA0123456Control #1 #2
mtHSP70 siRNA00.20.40.60.811.2Control #1 #2Relative band intensitycyt. HSP70PHX (nM)00.511.522.53DMSO 400. ***
***0123456mRNA Fold Induction after hspa9 knockdown (Normalized to Control siRNA-treated sample) cpt1a scd1 lpgat1 hsd17b12 acc1 acc2 srebp1 fas hspa9**** **C
GFP
Q78PolyQ
expressing cellsFilter Trap (anti-GFP)mtHSP70 siRNA #2double siRNA transfectionACC FAS Ctrl
onlysiRNA:#1 #2 #1 #2 Ctrl1 2 3 4 5 6Total Protein (anti-GFP)
1 2 3 4 5 6
GFPQ78TubulinTubulinGFP Q7800.511.522.533.541 2 3 4 5 1 2 3 4 5acc1mRNA Fold Induction after siRNA treatment(Normlized to Control siRNA-treated sample)00.511.522.533.541 2 3 4 5 1 2 3 4 5fas00.20.40.60.811 2 3 4 5 1 2 3 4 5hspa9*** * * ***** ********
********
***
**D
.Figure S6. MCSR Increased Expression of Cytosolic HSP70, and Fat Synthesis Is Also Required for MCSR Induction in Human Primary Fi-
broblasts, Related toFigure 7
(A) Western blotting analysis of mtHSP70 and cytosolic HSP70 (cyt. HSP70) proteins level after siRNA treatment or PHX treatment on human primary fibroblasts
(GFP expressing cells). Three independent biological repeats are shown in one gel. Relative band intensity was analyzed using ImageJ software (Bar graphs, *p%
0.05, **p%0.001,dp = 0.0560.).
(B) Triglyceride content of human primary fibroblasts (GFP expressing cells) was measured after PHX treatment (paired t test, mean±SD of three biological
repeats, p%0.05).
(legend continued on next page)